Loading clinical trials...
Loading clinical trials...
Evaluating the Use of Microarray Pharmacogenetic Testing in Patients With Cancer
Conditions
Interventions
Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"
Locations
1
United States
Atrium Health Levine Cancer
Charlotte, North Carolina, United States
Start Date
July 18, 2025
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
February 2, 2026
NCT05468034
NCT04541381
NCT06713993
NCT07543159
NCT07489378
NCT06844383
Lead Sponsor
Wake Forest University Health Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions